The CHN1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the human B-lymphoblastoid Raji cell line. This product features targeted disruption of the CHN1 gene, generating a heterogeneous pool of loss-of-function mutations. The polyclonal format preserves genetic diversity, enabling robust analysis of CHN1-dependent phenotypes while minimizing clonal artifacts. Researchers can employ this model to dissect the functions of ??-chimerin in cytoskeletal dynamics, cell adhesion, and signal transduction without the confounding effects of monoclonal variation.
Raji cells, originally established from an EBV-positive Burkitt lymphoma, are a widely used B-lymphocyte model characterized by a lymphoblastoid phenotype and potent B-cell receptor (BCR) signaling. These cells express surface immunoglobulins and the machinery for antigen presentation, making them an ideal system for studying humoral immunity and B-cell malignancies. The Raji background provides a physiologically relevant environment to interrogate CHN1 function, particularly given the line??s established utility in assays for adhesion, migration, and immune synapse formation.
CHN1 encodes ??-chimerin, a Rac-specific GTPase-activating protein (GAP) that negatively regulates Rac1 by accelerating GTP hydrolysis. BCR stimulation activates Src family kinases and PI3K, promoting VAV-mediated Rac1 activation and subsequent engagement of downstream effectors including PAK, LIMK, and cofilin. ??-Chimerin counterbalances this pathway by inactivating Rac1, thereby modulating actin cytoskeleton reorganization driven by the ARP2/3 complex. Additionally, ??-chimerin interacts with diacylglycerol (DAG) and protein kinase C (PKC), integrating second messenger signals. This control regulates adhesion, migration, and morphological responses downstream of BCR engagement.
In the Raji B-cell context, disruption of CHN1 is predicted to potentiate Rac1 activity, leading to enhanced PAK, LIMK, and cofilin activation, with consequent effects on actin polymerization and cellular adhesion. This knockout model offers a unique tool to investigate the balance between Rac activation and inactivation in lymphoblastoid cells, which is particularly relevant for understanding the molecular underpinnings of B-cell lymphomas and processes such as metastatic dissemination. By removing negative regulation, researchers can dissect the contribution of Rac hyperactivation to transformed B-cell phenotypes.
These polyclonal knockout cells are ideally suited for a range of mechanistic and translational studies, including functional analysis of Rac signaling in B-cell adhesion and activation, drug screening for Rac pathway modulators, and investigation of immune synapse formation. Representative assays encompass western blotting for Rac-GTP and phosphorylated PAK, flow cytometry for adhesion markers such as LFA-1, transwell migration experiments, immunofluorescence staining of F-actin, co-immunoprecipitation of CHN1-Rac complexes, and BCR stimulation assays. Apoptosis assays can also assess the impact of CHN1 loss on cell survival. For additional product details and technical support, please contact Ascent Research.
